A novel tool has been developed that could help researchers distinguish between bacterial and non-bacterial infection in patients hospitalized with lower respiratory tract infection.
Researchers have uncovered a therapeutic delivery method for nitric oxide in the treatment of dermal Trichophyton rubrum dermatophytosis; providing an alternative treatment to the systemic therapies currently used.
The impact of climate change on infectious diseases in Europe has been assessed in the first large-scale study, with results suggesting the affects could be greater than previously thought.
Researchers have reported that 86% of heterosexuals at high-risk for HIV would use a home-based testing kit sent by post, and almost all of these individuals would seek medical advice following a positive result.
A chikungunya vaccine, developed by Themis Bioscience GmbH will be assessed for safety and efficacy in Phase II trials in Puerto Rico from August 2017.
A child born with HIV has been found to suppress the infection without the reliance on conventional antiretroviral therapy; this may have future implications on the therapeutic approaches to HIV especially in infants.
Researchers from the Washington University School of Medicine examined the role of yersiniabactin (Ybt) in copper import in bacteria. Their findings indicate that bacteria are able to utilize Ybt to obtain copper as a source of nutrition.
A new analysis has suggested that the notion of ‘completing the course’ when taking antibiotics is not evidence-based and should be dropped as it may actually increase the risk of antibiotic resistance.
A vaginal ring, hoped to prevent HIV, has been reported to be safe and acceptable in a US study examining use in teenage girls, a particular risk group for this virus.
Results from the early-stage APPROACH trial have demonstrated an investigational HIV vaccine regimen, based on mosaic vaccines, has been well-tolerated and immunogenic in healthy participants.